Stay updated with breaking news from Delivery Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novartis has introduced its T-Charge platform at ASH 2021, which it says will serve as the foundation for various new investigational CAR-T cell therapies in its pipeline.
Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.
Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.
The US agency has granted approval to Voxzogo, an injectable drug designed to aid growth in children with achondroplasia, the most common form of dwarfism.
As COVID-19 vaccines roll out, low- and middle-income countries are facing a massive syringe shortage. PATH experts unpack the causes and implications.